<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC7242729\results\search\disease\results.xml">
  <result pre="University of La LagunaSan CristÃ³bal de La LagunaSpain[], 3Division of" exact="Pulmonary" post="and Critical Care Medicine, Eastern Virginia Medical SchoolNorfolkVAUnited States[],"/>
  <result pre="(CIBERCV)MadridSpain Edited by: Zisis Kozlakidis, International Agency for Research on" exact="Cancer" post="(IARC), France Reviewed by: Irene Crespo, University of LeÃ³n,"/>
  <result pre="Reiter reiter@uthscsa.edu Alberto Dominguez-Rodriguez adrvdg@hotmail.com This article was submitted to" exact="Infectious" post="Diseases â€&quot; Surveillance, Prevention and Treatment, a section of"/>
  <result pre="reiter@uthscsa.edu Alberto Dominguez-Rodriguez adrvdg@hotmail.com This article was submitted to Infectious" exact="Diseases" post="â€&quot; Surveillance, Prevention and Treatment, a section of the"/>
  <result pre="and killed tens of thousands of individuals worldwide. This highly" exact="infectious" post="condition continues to ravage the world population and has"/>
  <result pre="the world population and has yet to reach it peak" exact="infective" post="rate in some countries. Many conventional drugs including hydroxychloroquine/chloroquine,"/>
  <result pre="in combination with currently-recommended drugs, e.g., hydroxychloroquine/chloroquine, to resist COVID-19" exact="infection" post="would seem judicious. melatonin COVID-19 SARS-CoV-2 treatment-drug prevention &amp;amp;"/>
  <result pre="~8,000 cases and 800 deaths. In 2002 the Middle East" exact="respiratory" post="syndrome coronavirus produced 2,500 cases with infection and caused"/>
  <result pre="cases and 800 deaths. In 2002 the Middle East respiratory" exact="syndrome" post="coronavirus produced 2,500 cases with infection and caused 800"/>
  <result pre="the Middle East respiratory syndrome coronavirus produced 2,500 cases with" exact="infection" post="and caused 800 deaths. The coronavirus disease 2019 (COVID-19)"/>
  <result pre="2,500 cases with infection and caused 800 deaths. The coronavirus" exact="disease" post="2019 (COVID-19) is highly contagious and has quickly spread"/>
  <result pre="and shortness of breath. These symptoms appear 2â€&quot;14 days after" exact="infection" post="(4, 5). The clinical picture varies from pausymptomatic to"/>
  <result pre="from pausymptomatic to more serious clinical situations such as severe" exact="respiratory" post="failure, sepsis, shock, and multiple organ dysfunction syndrome (6)."/>
  <result pre="as severe respiratory failure, sepsis, shock, and multiple organ dysfunction" exact="syndrome" post="(6). Currently, there is no specific treatment for COVID-19,"/>
  <result pre="has quickly realized that there is no cure for this" exact="disease" post="and vaccines will not be available for several months."/>
  <result pre="a well-known chronobiotic, is also a promising adjunctive drug for" exact="viral" post="infections due to its anti-inflammatory, antiapoptotic, immunomodulatory, and powerful"/>
  <result pre="well-known chronobiotic, is also a promising adjunctive drug for viral" exact="infections" post="due to its anti-inflammatory, antiapoptotic, immunomodulatory, and powerful antioxidant"/>
  <result pre="With COVID-19 Little is known about the crucial factors of" exact="disease" post="severity and immune alteration produced by COVID-19 infection in"/>
  <result pre="factors of disease severity and immune alteration produced by COVID-19" exact="infection" post="in humans (9). Cytokines and chemokines play important roles"/>
  <result pre="shown that the cytokine storm dampens adaptive immunity against COVID-19" exact="infection" post="(10). Chen et al. (11) have recently demonstrated immunological"/>
  <result pre="apoptosis, pyroptosis, and necrosis even of non-infected cells (13). COVID-19" exact="infection" post="may attack the melatonin synthetic pathway resulting in reduced"/>
  <result pre="at a time when melatonin is most needed (14). The" exact="uncontrolled" post="innate immune response promotes a massive inflammatory reaction and"/>
  <result pre="melatonin synthesized in the pineal gland is &amp;lt;5% of the" exact="total" post="melatonin produced. The melatonin produced in the mitochondria is"/>
  <result pre="and in the promotion of the different stages of the" exact="viral" post="life cycle. The fact that melatonin is a regulator"/>
  <result pre="beneficial role for this molecule in the management of some" exact="viral" post="infections (17). Viruses, including Ebola, dengue, encephalomyocarditis, Venezuelan equine"/>
  <result pre="role for this molecule in the management of some viral" exact="infections" post="(17). Viruses, including Ebola, dengue, encephalomyocarditis, Venezuelan equine encephalitis,"/>
  <result pre="of some viral infections (17). Viruses, including Ebola, dengue, encephalomyocarditis," exact="Venezuelan equine encephalitis," post="rabbit hemorrhagic disease, human papilloma, and inter alia, have"/>
  <result pre="(17). Viruses, including Ebola, dengue, encephalomyocarditis, Venezuelan equine encephalitis, rabbit" exact="hemorrhagic disease," post="human papilloma, and inter alia, have demonstrated the success"/>
  <result pre="alia, have demonstrated the success of melatonin in protecting against" exact="viral" post="infections. There is no evidence that melatonin is viricidal"/>
  <result pre="is viricidal but rather it reduces the severity of these" exact="infections" post="(18â€&quot;21). Melatonin's beneficial effects derive from its anti-inflammatory properties,"/>
  <result pre="of the coronavirus familyâ€� (22). The cytokine storm leads to" exact="acute" post="cardiac injury, acute respiratory distress syndrome, and infection, leading"/>
  <result pre="familyâ€� (22). The cytokine storm leads to acute cardiac injury," exact="acute" post="respiratory distress syndrome, and infection, leading to generalized sepsis"/>
  <result pre="(22). The cytokine storm leads to acute cardiac injury, acute" exact="respiratory" post="distress syndrome, and infection, leading to generalized sepsis and"/>
  <result pre="been suggested, due to a decrease in the concentration of" exact="nocturnal" post="melatonin levels in the elderly (23). It has been"/>
  <result pre="of age; therefore, they are more likely to develop severe" exact="pneumonia" post="due to COVID-19 (25). Recent studies have shown that"/>
  <result pre="is a biological process that contributes to an increase in" exact="cardiovascular" post="morbidity and mortality. In the HEIJO-KYO cohort (cohort of"/>
  <result pre="Japanese patients), urinary excretion of melatonin was associated with reduced" exact="nocturnal" post="systolic blood pressure, independent of other cardiovascular risk factors."/>
  <result pre="associated with reduced nocturnal systolic blood pressure, independent of other" exact="cardiovascular" post="risk factors. More precisely, an increase in urinary melatonin"/>
  <result pre="4.2 to 10.5 Î¼g caused a 2 mmHg decrease in" exact="nocturnal" post="systolic blood pressure. Patients who took melatonin at a"/>
  <result pre="uniformly showed a reduction in night-time blood pressure (28, 29)." exact="Obesity" post="is a risk factor for cardiovascular disease. In different"/>
  <result pre="blood pressure (28, 29). Obesity is a risk factor for" exact="cardiovascular disease." post="In different studies, melatonin has been shown to have"/>
  <result pre="a relationship with the physiological processes of wakefulness/sleep rhythm (32)." exact="Diabetes" post="is a risk factor for the development of cardiovascular"/>
  <result pre="(32). Diabetes is a risk factor for the development of" exact="cardiovascular" post="diseases. Several studies have shown a functional interaction between"/>
  <result pre="between insulin and melatonin, showing that diabetic subjects have a" exact="lower" post="concentration of melatonin (33). Furthermore, decreased blood melatonin levels"/>
  <result pre="levels have been documented in patients with insulin resistance or" exact="glucose intolerance" post="(34). The results of several studies suggest that low"/>
  <result pre="low melatonin production is associated with an increased risk of" exact="cardiovascular disease" post="(35â€&quot;37). Several studies have shown that 75% of COVID-19"/>
  <result pre="melatonin production is associated with an increased risk of cardiovascular" exact="disease" post="(35â€&quot;37). Several studies have shown that 75% of COVID-19"/>
  <result pre="Other authors have reported that patients with hypertension, obesity, and" exact="diabetes" post="are more likely to develop more severe COVID-19 infection,"/>
  <result pre="more severe COVID-19 infection, including death (40). The occurrence of" exact="heart" post="failure and myocardial infarction is plausible in these patients."/>
  <result pre="infection, including death (40). The occurrence of heart failure and" exact="myocardial infarction" post="is plausible in these patients. The immune system of"/>
  <result pre="patients is altered, with a reduced immune response (40). Furthermore," exact="obesity" post="contributes to various chronic diseases; decreased immunity and subsequently"/>
  <result pre="a reduced immune response (40). Furthermore, obesity contributes to various" exact="chronic" post="diseases; decreased immunity and subsequently an increased risk of"/>
  <result pre="chronic diseases; decreased immunity and subsequently an increased risk of" exact="infection" post="(41). Therefore, medical comorbidities are a risk factor for"/>
  <result pre="an inappropriate amount (Figure 1). Figure 1 Prevention of COVID-19" exact="infections" post="in the elderly, in individuals with comorbidities and in"/>
  <result pre="in time to be helpful to the currently or soon-to-be" exact="infective" post="population (47). In our view, this tragedy cannot be"/>
  <result pre="sepsis (43), where the clinical features parallel those of COVID-19" exact="viral infection;" post="moreover, melatonin has been demonstrated to relieve many of"/>
  <result pre="been demonstrated to relieve many of the symptoms of other" exact="viral" post="infections (17â€&quot;21, 48). Given the current worldwide situation and"/>
  <result pre="demonstrated to relieve many of the symptoms of other viral" exact="infections" post="(17â€&quot;21, 48). Given the current worldwide situation and in"/>
  <result pre="pharmacological safety profile supports its use in the treatment of" exact="infectious diseases," post="such as COVID-19. Melatonin can also be useful as"/>
  <result pre="experience in the use of melatonin in the context of" exact="cardiovascular" post="physiology. Melatonin can be administered at a total dose"/>
  <result pre="context of cardiovascular physiology. Melatonin can be administered at a" exact="total" post="dose of at least 120 to 1,000 Î¼g/kg/subject weight"/>
  <result pre="(36, 37). An aggressive approach is required to prevent coronavirus" exact="disease" post="progression and mechanical ventilation. Nordlund and Lerner (49) published"/>
  <result pre="this crisis has. The high mortality is caused by the" exact="uncontrolled" post="innate immune response and destructive inflammation. Melatonin is a"/>
  <result pre="The authors declare that the research was conducted in the" exact="absence of" post="any commercial or financial relationships that could be construed"/>
  <result pre="wave of SARS-CoV-2?Lancet. (2020) 395:947. 10.1016/S0140-6736(20)30521-332145187 3.collab: European Centre for" exact="Disease" post="Prevention Control, (2020). Available online at: https://www.ecdc.europa.eu/en/novel-coronavirus-china (accessed March"/>
  <result pre="(accessed March 31, 2020). 4.GuanWJNiZYHuYLiangWHOuCQHeJXet al.. Clinical characteristics of coronavirus" exact="disease" post="2019 in China. N Engl J Med. (2020) 382:1708â€&quot;20."/>
  <result pre="N Engl J Med. (2020) 382:1708â€&quot;20. 10.1056/NEJMoa200203232109013 5.ZouLRuanFHuangMLiangLHuangHHongZet al.. SARS-CoV-2" exact="viral" post="load in upper respiratory specimens of infected patients. N"/>
  <result pre="Med. (2020) 382:1708â€&quot;20. 10.1056/NEJMoa200203232109013 5.ZouLRuanFHuangMLiangLHuangHHongZet al.. SARS-CoV-2 viral load in" exact="upper" post="respiratory specimens of infected patients. N Engl J Med."/>
  <result pre="(2020) 382:1708â€&quot;20. 10.1056/NEJMoa200203232109013 5.ZouLRuanFHuangMLiangLHuangHHongZet al.. SARS-CoV-2 viral load in upper" exact="respiratory" post="specimens of infected patients. N Engl J Med. (2020)"/>
  <result pre="guidelines on the management of critically ill adults with coronavirus" exact="disease" post="2019 (COVID-19). Intensive Care Med. (2020). 10.1007/s00134-020-06022-5. [Epub ahead"/>
  <result pre="and functional exhaustion of T cells in patients with coronavirus" exact="disease" post="2019 (COVID-19). Front. Immunol. (2020) 11:82710.3389/fimmu.2020.0082732425950 10.ChannappanavarRFehrARVijayRMackMZhaoJMeyerholzDKet al.. Dysregulated"/>
  <result pre="disease 2019 (COVID-19). Front. Immunol. (2020) 11:82710.3389/fimmu.2020.0082732425950 10.ChannappanavarRFehrARVijayRMackMZhaoJMeyerholzDKet al.. Dysregulated" exact="type I" post="interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in"/>
  <result pre="Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal" exact="pneumonia" post="in SARS-CoV-infected mice. Cell Host Microbe. (2016) 19:181â€&quot;93. 10.1016/j.chom.2016.01.00726867177"/>
  <result pre="11.ChenGWuDGuoWCaoYHuangDWangHet al.Clinical and immunologic features in severe and moderate coronavirus" exact="disease" post="2019. J Clin Invest. (2020) 130:2620â€&quot;29. 10.1172/JCI13724432217835 12.LiaoMYangLYuanJWenYXuGZhaoJet al.The"/>
  <result pre="sequencing. medRxiv. (2020). 10.1101/2020.02.23.20026690. [Epub ahead of print]. 13.HuoCJinYZouSQiPXiaoJTianHet al.." exact="Lethal" post="influenza A virus preferentially activates TLR3 and triggers a"/>
  <result pre="inflammatory response. Virus Res. (2018) 257:102â€&quot;12. 10.1016/j.virusres.2018.09.01230248373 14.GrunewaldMEShabanMGMackinSRFehrARPerlmanS. Murine coronavirus" exact="infection" post="activates the aryl hydrocarbon receptor in an indoleamine 2,3-dioxygenase-independent"/>
  <result pre="signaling in an animal model of fulminant hepatic failure of" exact="viral" post="origin. J Pineal Res. (2010) 49:193â€&quot;200. 10.1111/j.1600-079X.2010.00787.x20609075 21.ValeroNMosqueraJAlcocerSBonillaESalazarJÃ�lvarez-MonM. Melatonin,"/>
  <result pre="21.ValeroNMosqueraJAlcocerSBonillaESalazarJÃ�lvarez-MonM. Melatonin, minocycline and ascorbic acid reduce oxidative stress and" exact="viral" post="titers and increase survival rate in experimental Venezuelan equine"/>
  <result pre="stress and viral titers and increase survival rate in experimental" exact="Venezuelan equine encephalitis." post="Brain Res. (2015) 1622:368â€&quot;76. 10.1016/j.brainres.2015.06.03426168898 22.collab: MedicalXpress Breaking News"/>
  <result pre="titers and increase survival rate in experimental Venezuelan equine encephalitis." exact="Brain" post="Res. (2015) 1622:368â€&quot;76. 10.1016/j.brainres.2015.06.03426168898 22.collab: MedicalXpress Breaking News and"/>
  <result pre="severity and improve the prognosis of patients with novel coronavirus" exact="disease" post="(COVID-19). J Intern Med. (2020). 10.1111/joim.13063. [Epub ahead of"/>
  <result pre="83:163â€&quot;71. 10.1111/bcp.1290226852373 30.GubinDGGubinGDGaponLIWeinertD. Daily melatonin administration attenuates age-dependent disturbances of" exact="cardiovascular" post="rhythms. Curr Aging Sci. (2016) 9:5â€&quot;13. 10.2174/187460980966615113022001126632428 31.ImenshahidiMKarimiGHosseinzadehHEffects of"/>
  <result pre="Curr Aging Sci. (2016) 9:5â€&quot;13. 10.2174/187460980966615113022001126632428 31.ImenshahidiMKarimiGHosseinzadehHEffects of melatonin on" exact="cardiovascular" post="risk factors and metabolic syndrome: a comprehensive review. Naunyn"/>
  <result pre="Pharmacol. (2020) 393:521â€&quot;36. 10.1007/s00210-020-01822-4 32.PradoNJFerderLManuchaWDiezER. Anti-inflammatory effects of melatonin in" exact="obesity" post="and hypertension. Curr Hypertens Rep. (2018) 20:45. 10.1007/s11906-018-0842-629744660 33.Cipolla-NetoJAmaralFGAfecheSCTanDXReiterRJ."/>
  <result pre="a review. J Pineal Res. (2014) 56:371â€&quot;81. 10.1111/jpi.1213724654916 34.ReutrakulSSumritsopakRSaetungSChanprasertyothinSChailurkitLOAnothaisintaweeT. Lower" exact="nocturnal" post="urinary 6-sulfatoxymelatonin is associated with more severe insulin resistance"/>
  <result pre="with reverse remodeling after cardiac resynchronization therapy in patients with" exact="heart" post="failure and ventricular dyssynchrony. Int J Cardiol. (2016) 221:359â€&quot;63."/>
  <result pre="melatonin to reduce infarct size in patients with ST-segment elevation" exact="myocardial infarction" post="receiving percutaneous coronary intervention (from the melatonin adjunct in"/>
  <result pre="receiving percutaneous coronary intervention (from the melatonin adjunct in the" exact="acute" post="myocardial infarction treated with angioplasty trial). Am J Cardiol."/>
  <result pre="percutaneous coronary intervention (from the melatonin adjunct in the acute" exact="myocardial infarction" post="treated with angioplasty trial). Am J Cardiol. (2017) 120:522â€&quot;6."/>
  <result pre="Effect of intravenous and intracoronary melatonin as an adjunct to" exact="primary" post="percutaneous coronary intervention for acute ST-elevation myocardial infarction: results"/>
  <result pre="melatonin as an adjunct to primary percutaneous coronary intervention for" exact="acute" post="ST-elevation myocardial infarction: results of the melatonin adjunct in"/>
  <result pre="ST-elevation myocardial infarction: results of the melatonin adjunct in the" exact="acute" post="myocardial infarction treated with angioplasty trial. J Pineal Res."/>
  <result pre="myocardial infarction: results of the melatonin adjunct in the acute" exact="myocardial infarction" post="treated with angioplasty trial. J Pineal Res. (2017) 62."/>
  <result pre="(2020) 26:1052â€&quot;4. 10.3201/eid2605.20019832091386 40.MadjidMSafavi-NaeiniPSolomonSDVardenyO. Potential effects of coronaviruses on the" exact="cardiovascular" post="system: a review. JAMA Cardiol. (2020). 10.1001/jamacardio.2020.1286. [Epub ahead"/>
  <result pre="JAMA Cardiol. (2020). 10.1001/jamacardio.2020.1286. [Epub ahead of print]. 32219363 41.HuttunenRSyrjÃ¤nenJ." exact="Obesity" post="and the risk and outcome of infection. Int J"/>
  <result pre="Clin Endocrinol Metab. (1977) 45:768â€&quot;74. 10.1210/jcem-45-4-768914981 50.RamosEFarrÃ©-AlinsVEgeaJLÃ³pez-MuÃ±ozFReiterRJRomeroA. Melatonin's efficacy in" exact="stroke" post="patients; a matter of dose? A systematic review. Toxicol"/>
  <result pre="392:114933. 10.1016/j.taap.2020.11493332112789 51.AndersonGReiterRJ. Melatonin: roles in influenza, Covid-19, and other" exact="viral" post="infections. Rev Med Virol. (2020). 10.1002/rmv.2109. [Epub ahead of"/>
 </snippets>
</snippetsTree>
